European medicines regulators have issued a notice that an ingredient for a generic brain cancer drug made in China does not meet manufacturing standards, after inspectors were refused entry to a factory run by Jiangsu Yew Pharmaceutical Co. Ltd.
from Reuters: Health https://ift.tt/2Oczotv
via IFTTT
0 comments: